A Clinical Study of Sequential Immunotherapy and Chemotherapy After Concurrent Chemoradiotherapy for Conversion Treatment in Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ChiCTR) - Oct 16, 2026 - P2 | N=45 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Soochow University; The First Affiliated Hospital of Soochow University
New P2 trial • Esophageal Cancer • Esophageal Squamous Cell Carcinoma • Oncology • Squamous Cell Carcinoma
|